A futuristic perspective on clinical studies of cardiac resynchronization therapy for heart failure patients

Current Opinion in Cardiology

Volumn 21, Issue 2, 2006, Pages 78-82

  Tang, Anthony S L ^a   Ellenbogen, Kenneth A ^b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac resynchronization therapy; Heart failure; Ventricular dyssynchrony

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL STUDY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE SEVERITY; HEART DEATH; HEART FAILURE; HEART PACING; HEART STIMULATION; HEART VENTRICLE; HUMAN; MEDICAL INSTRUMENTATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ARRHYTHMIA; CAUSE OF DEATH; DEFIBRILLATORS, IMPLANTABLE; DOUBLE-BLIND METHOD; FORECASTING; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; PACEMAKER, ARTIFICIAL; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33748608001     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000203840.72902.39     Document Type: Review

References (35)

1. Stewart S, MacIntyre K, Capewell S, McMurray JJ. Heart failure and the aging population: an increasing burden in the 21st century? Heart 2003; 89:49-53.
2. Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999; 137:352-360.
3. CONSENSUS study group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316:1429-1435.
4. SOLVD Investigators. The effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
5. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334:1349-1355.
6. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353:2001-2007.
7. CIBIS-II investigators. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999; 353:9-13.
8. Pitt B, Zannad F, Remme WJ, et al. The effects of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709-716.
9. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347:1397-1402.
10. Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998; 19:696-710.
11. Koga Y, Wada T, Toshima H, et al. Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy. Heart Vessels 1993; 8:37-41.
12. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circ 1997; 95:2660-2667.
13. Yu CM, Fung JW, Zhang Q, et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circ 2004; 110:66-73. This study concluded that postsystolic shortening is useful only for nonischemic pathogenesis, whereas the role of strain rate imaging parameters was not supported.
14. Auricchio A, Yu CM. Beyond the measurement of QRS complex toward mechanical dyssynchrony: cardiac resynchronisation therapy in heart failure patients with a normal QRS duration. Heart 2004; 90:479-481. These authors show that more patients may derive benefit from cardiac resynchronization therapy than previously thought.
15. Hochleitner M, Hortnagl H, Ng CK, et al. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66:198-202.
16. Hochleitner M, Hortnagl H, Hortnagl H, et al. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 70:1320-1325.
17. Linde C, Gadler F, Edner M, et al. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995; 75:919-923.
18. Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995; 26:967-973.
19. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288:3115-3123.
20. Cazeau S, Ritter P, Lazarus A, et al. Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol 1996; 19:1748-1757.
21. Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure. Results of an acute hemodynamic study. Circ 1997; 96:3273-3277.
22. Saxon LA, Kerwin WF, Cahalan MK, et al. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol 1998; 9:13-21.
23. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circuation 1999; 99:1567-1573.
24. Gras D, Mabo P, Tang ASL, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync study. Pacing Clin Electrophysiol 1998; 6:171-184.
25. Bakker PF, Meijburg HW, de Vries JW, et al. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J Interv Card Electrophysiol 2000; 4:395-404.
26. Leclercq C, Cazeau S, Ritter P, et al. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000; 140:862-870.
27. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999; 99:2993-3001.
28. Higgins SL, Yong P, Sheck D, et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators. J Am Coll Cardiol 2000; 36:824-827.
29. Walker S, Levy TM, Rex S, et al. Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe cardiac failure. Am J Cardiol 2000; 86:231-233.
30. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344:873-880.
31. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
32. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42:1454-1459.
33. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003; 289:2685-2694.
34. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.
35. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-1549.